Home/Tag: Harvard

Accelerating Innovation in Precision Medicine

Sara Rothschild, VP Programs and Services at the LRG, attended an executive education program at the Harvard Business School which brought together leaders from the health care, scientific, technological, and business communities to speed progress and drive cures.

By |2019-12-19T11:25:32-05:00November 3rd, 2019|News, Survival Strategies|

LRG Research Team members publish results of imatinib combination study

Drs. Jonathan Fletcher, of Brigham & Women’s Hospital, Harvard University and Maria Debiec-Rychter, of the Catholic University in Leuven, Belgium, members of the LRG Research Team were part of a recently published study that looked at the effectiveness of GDC-0941, a PI3K inhibitor when used in combination with imatinib (Gleevec).

By |2019-09-20T13:20:42-04:00February 1st, 2013|News, Research|
Go to Top